These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24721648)

  • 1. Cardiac and renal inward rectifier potassium channel pharmacology: emerging tools for integrative physiology and therapeutics.
    Swale DR; Kharade SV; Denton JS
    Curr Opin Pharmacol; 2014 Apr; 15():7-15. PubMed ID: 24721648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities.
    Bhave G; Lonergan D; Chauder BA; Denton JS
    Future Med Chem; 2010 May; 2(5):757-74. PubMed ID: 20543968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening Technologies for Inward Rectifier Potassium Channels: Discovery of New Blockers and Activators.
    Walsh KB
    SLAS Discov; 2020 Jun; 25(5):420-433. PubMed ID: 32292089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ML418: The First Selective, Sub-Micromolar Pore Blocker of Kir7.1 Potassium Channels.
    Swale DR; Kurata H; Kharade SV; Sheehan J; Raphemot R; Voigtritter KR; Figueroa EE; Meiler J; Blobaum AL; Lindsley CW; Hopkins CR; Denton JS
    ACS Chem Neurosci; 2016 Jul; 7(7):1013-23. PubMed ID: 27184474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation inward rectifier potassium channel modulators: discovery and molecular pharmacology.
    Weaver CD; Denton JS
    Am J Physiol Cell Physiol; 2021 Jun; 320(6):C1125-C1140. PubMed ID: 33826405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992.
    Kharade SV; Kurata H; Bender AM; Blobaum AL; Figueroa EE; Duran A; Kramer M; Days E; Vinson P; Flores D; Satlin LM; Meiler J; Weaver CD; Lindsley CW; Hopkins CR; Denton JS
    Mol Pharmacol; 2018 Aug; 94(2):926-937. PubMed ID: 29895592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels.
    McClenahan SJ; Kent CN; Kharade SV; Isaeva E; Williams JC; Han C; Terker A; Gresham R; Lazarenko RM; Days EL; Romaine IM; Bauer JA; Boutaud O; Sulikowski GA; Harris R; Weaver CD; Staruschenko A; Lindsley CW; Denton JS
    Mol Pharmacol; 2022 May; 101(5):357-370. PubMed ID: 35246480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of fluorescence-based and automated patch clamp-based functional assays for the inward rectifier potassium channel Kir4.1.
    Raphemot R; Kadakia RJ; Olsen ML; Banerjee S; Days E; Smith SS; Weaver CD; Denton JS
    Assay Drug Dev Technol; 2013; 11(9-10):532-43. PubMed ID: 24266659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cardiac inward rectifier currents by cationic amphiphilic drugs.
    van der Heyden MA; Stary-Weinzinger A; Sanchez-Chapula JA
    Curr Mol Med; 2013 Sep; 13(8):1284-98. PubMed ID: 23448372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput screening for small-molecule modulators of inward rectifier potassium channels.
    Raphemot R; Weaver CD; Denton JS
    J Vis Exp; 2013 Jan; (71):. PubMed ID: 23381507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the Development of AgoKirs: New Pharmacological Activators to Study K
    van der Schoor L; van Hattum EJ; de Wilde SM; Harlianto NI; van Weert AJ; Bloothooft M; van der Heyden MAG
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inward rectifier potassium (Kir) channels in the retina: living our vision.
    Beverley KM; Pattnaik BR
    Am J Physiol Cell Physiol; 2022 Sep; 323(3):C772-C782. PubMed ID: 35912989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.x, and Kir7.1.
    Raphemot R; Lonergan DF; Nguyen TT; Utley T; Lewis LM; Kadakia R; Weaver CD; Gogliotti R; Hopkins C; Lindsley CW; Denton JS
    Front Pharmacol; 2011; 2():75. PubMed ID: 22275899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein trafficking and anchoring complexes revealed by proteomic analysis of inward rectifier potassium channel (Kir2.x)-associated proteins.
    Leonoudakis D; Conti LR; Anderson S; Radeke CM; McGuire LM; Adams ME; Froehner SC; Yates JR; Vandenberg CA
    J Biol Chem; 2004 May; 279(21):22331-46. PubMed ID: 15024025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spermine is fit to block inward rectifier (Kir) channels.
    Stanfield PR; Sutcliffe MJ
    J Gen Physiol; 2003 Nov; 122(5):481-4. PubMed ID: 14581580
    [No Abstract]   [Full Text] [Related]  

  • 16. The molecular basis of chloroethylclonidine block of inward rectifier (Kir2.1 and Kir4.1) K(+) channels.
    Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
    Pharmacol Rep; 2016 Apr; 68(2):383-9. PubMed ID: 26922543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kir Channel Blockages by Proflavine Derivatives via Multiple Modes of Interaction.
    Inanobe A; Itamochi H; Kurachi Y
    Mol Pharmacol; 2018 Jun; 93(6):592-600. PubMed ID: 29650538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific residues of the cytoplasmic domains of cardiac inward rectifier potassium channels are effective antifibrillatory targets.
    Noujaim SF; Stuckey JA; Ponce-Balbuena D; Ferrer-Villada T; López-Izquierdo A; Pandit S; Calvo CJ; Grzeda KR; Berenfeld O; Chapula JA; Jalife J
    FASEB J; 2010 Nov; 24(11):4302-12. PubMed ID: 20585026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of the K(ir)2 family of inward rectifier potassium channels by a small molecule probe: the discovery, SAR, and pharmacological characterization of ML133.
    Wang HR; Wu M; Yu H; Long S; Stevens A; Engers DW; Sackin H; Daniels JS; Dawson ES; Hopkins CR; Lindsley CW; Li M; McManus OB
    ACS Chem Biol; 2011 Aug; 6(8):845-56. PubMed ID: 21615117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1.
    Lewis LM; Bhave G; Chauder BA; Banerjee S; Lornsen KA; Redha R; Fallen K; Lindsley CW; Weaver CD; Denton JS
    Mol Pharmacol; 2009 Nov; 76(5):1094-103. PubMed ID: 19706730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.